IASLC WCLC 2021: Pneumonitis With Durvalumab in Non–Small Cell Lung Cancer May Be More Frequent Than Clinical Data Indicate
Larger studies are needed to confirm the findings and identify other risk factors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.